SUMMIT THERAPEUTICS INC (SMMT)
US86627T1088 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-1-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 71.42M | 348.60M | 71.80M | 66.40M | 35.20M | |||
| Marketable Securities | 114.82M | N/A | N/A | N/A | N/A | |||
| Receivables | 848.00K | 6.10M | 17.20M | 10.20M | 14.40M | |||
| Other Current Assets | 2.62M | 302.00M | 8.40M | 11.00M | 11.60M | |||
| Total Current Assets | 189.71M | 656.70M | 97.30M | 87.70M | 61.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.06M | 5.10M | 3.50M | 1.30M | 2.00M | |||
| Goodwill | 1.89M | 1.80M | 2.00M | 2.00M | 2.40M | |||
| Intangibles | N/A | 0.00 | 10.40M | 11.50M | 13.90M | |||
| Other Non-Current Assets | 4.32M | 600.00K | 200.00K | N/A | N/A | |||
| Total Non-Current Assets | 13.24M | 7.50M | 16.10M | 14.80M | 18.30M | |||
| TOTAL ASSETS | 202.95M | 664.20M | 113.40M | 102.50M | 79.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 19.80M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 360.00K | |||
| Accrued Expenses | 17.02M | 18.00M | 12.40M | 4.70M | 5.70M | |||
| Accounts Payable | 2.67M | 400.00K | 4.40M | 6.10M | 5.80M | |||
| Other Current Liabilities | 717.00K | 700.00K | 8.80M | 9.10M | 5.70M | |||
| Total Current Liabilities | 20.41M | 38.80M | 25.60M | 19.90M | 17.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 100.00M | 494.50M | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 2.20M | |||
| Other Non-Current Liabilities | 4.85M | 4.20M | 4.50M | 3.20M | 4.40M | |||
| Total Non-Current Liabilities | 104.85M | 498.70M | 4.50M | 3.10M | 6.60M | |||
| TOTAL LIABILITIES | 125.26M | 537.50M | 30.10M | 23.00M | 23.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -993.26M | -378.30M | -299.50M | -210.90M | -130.90M | |||
| Additional Paid In Capital | 1.07B | 504.80M | 384.00M | 293.40M | 191.20M | |||
| Common Shares | 7.02M | 2.10M | 1.00M | 800.00K | 300.00K | |||
| Other Shareholders' Equity | -2.45M | -1.90M | -2.20M | -3.80M | -4.80M | |||
| Shares Outstanding | 701.66M | 211.10M | 98.00M | 82.60M | 32.10M | |||
| Tangible Book Value per Share | 0.11 | 0.59 | 0.72 | 0.80 | 1.23 | |||
| Total Shareholders' Equity | 77.69M | 126.70M | 83.30M | 79.50M | 55.80M | |||
| TOTAL LIABILITIES AND EQUITY | 202.95M | 664.20M | 113.40M | 102.50M | 79.60M | |||
| Statistics | ||||||||
| Debt/Equity | 1.29 | 4.06 | N/A | N/A | N/A | |||
| Current Ratio | 9.30 | 16.93 | 3.80 | 4.41 | 3.56 | |||
| Return On Assets (ROA) | -303.00% | -11.86% | -78.13% | -51.41% | 12.44% | |||
| Return On Equity (ROE) | -791.49% | -62.18% | -106.36% | -66.29% | 17.74% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 14.29% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 32.79% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 81.83% | |||
All data in USD